2
In today's world, shaped by the aftermath of the COVID-19 pandemic, there is no doubt that lower respiratory tract infections (LRTIs) pose a substantial global health and economic threat. They are a significant cause of morbidity and mortality worldwide, particularly during the winter months due to seasonal respiratory epidemics. With the changing genetic landscape of virus strains post-COVID 1 , the critical role of diagnostics in managing patient outcomes and optimizing healthcare resources is amplified. Traditionally, the diagnostic process has revolved around identifying single targets. The newer multiplexing approach, in contrast, allows for simultaneous identification of multiple pathogens, enabling healthcare providers rapid insight and a comprehensive diagnostic profile. Overall, multiplexing has proven to accelerate diagnoses, create cost efficiencies, optimize resources, and enhance patient care.
Powered by FlippingBook